V-Bio Fund 2

Gent ·KBO/BCE: BE 0759.685.291

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	02-06-2025	59 d early	2025-00114566
31-12-2023	31-07-2024	26-06-2024	35 d early	2024-00196139
31-12-2022	31-07-2023	23-06-2023	38 d early	2023-00157628
31-12-2021	31-07-2022	29-12-2022	151 d late	2022-20548931

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€28.21M
Fixed assets	21/28	€28.01M
Formation expenses	20	€42k
Financial fixed assets	28	€28.01M
Current assets	29/58	€157k
Amounts receivable within one year	40/41	€10k
Cash & bank	54/58	€147k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€28.21M
Equity	10/15	€27.68M
Contributions / capital	10/11	€38.18M
Accumulated profits (losses)	14	€-10.50M
Amounts payable	17/49	€532k
Amounts payable within one year	42/48	€532k
Trade debts payable within one year	44	€532k
Income statement
Gross operating margin	9900	€-2.13M
Operating result	9901	€-2.17M
Financial income	75	€10k
Result before taxes	9903	€-2.16M
Net result for the period	9904	€-2.16M
Result to be appropriated	9905	€-2.16M

Summary